![Logo for Idorsia Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fbc936-2023-05-12-02-52-05.png&w=256&q=100)
Idorsia Investor Relations Material
Latest events
![Logo for Idorsia Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fbc936-2023-05-12-02-52-05.png&w=128&q=100)
H1 2024
Idorsia
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Idorsia Ltd
Access all reports
Idorsia Ltd is a biopharmaceutical company based in Switzerland, specializing in the discovery, development, and commercialization of small molecules. The company targets a wide range of diseases, including Fabry disease, insomnia, resistant hypertension, cerebral vasospasm, epilepsy, nasal polyposis, and systemic lupus erythematosus, among others. Idorsia's approach spans multiple therapeutic areas such as CNS, cardiovascular, and immunological disorders, as well as orphan diseases. The company is headquartered in Allschwil, near Basel, Switzerland, and its shares are listed on the SIX Swiss Exchange.
Key slides for Idorsia Ltd
![X
llllll
3 9M 20](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fidorsia-ltd-q3-2023-161732df84761ea5%2F3.png&w=3840&q=75)
![Logo for Idorsia Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fbc936-2023-05-12-02-52-05.png&w=128&q=100)
Q3 2023
Idorsia Ltd
![Financial outlook](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fidorsia-ltd-h1-2024-a9adbbe683b3166e%2F12.png&w=3840&q=75)
![Logo for Idorsia Ltd](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fbc936-2023-05-12-02-52-05.png&w=128&q=100)
H1 2024
Idorsia Ltd
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
IDIA
Country
🇨🇭 Switzerland